The research project, led by Assoc. Prof. Dr. Sercan Ergün, a faculty member of Ondokuz Mayıs University (OMU) Department of Basic Medical Sciences, Department of Medical Biology, was entitled to be supported by the Scientific and Technological Research Council of Turkey (TÜBİTAK) within the scope of the 1002 Program.

Prof. Dr. Ayhan Dağdemir, Assoc. Prof. Dr. Özlem Terzi, Dr.  İbrahim Kartal, Dr. Seda Gün, and Dr. Oğuz Salih Dinçer are researchers in the study titled “Investigation of the relationship of miR-182, miR-320a, miR-144 with EBV-positive Burkitt lymphoma”, which is supported by TÜBİTAK.